Mu (μ) Opioid Receptor Regulation of Ethanol-Induced Dopamine Response in the Ventral Striatum: Evidence of Genotype Specific Sexual Dimorphic Epistasis

Biological Psychiatry

Volumn 62, Issue 6, 2007, Pages 627-634

  Job, Martin O ^a   Tang, Amanda ^a   Hall, F Scott ^b   Sora, Ichiro ^b   Uhl, George R ^b   Bergeson, Susan E ^a   Gonzales, Rueben A ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Dopamine; genotype; knockout mice; microdialysis; nucleus accumbens; sexual dimorphism

Indexed keywords

ALCOHOL; CALCIUM ION; DOPAMINE; MU OPIATE RECEPTOR; NALOXONAZINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DIALYSATE; DOPAMINE RECEPTOR BLOCKING; DOPAMINE RELEASE; DRUG EFFECT; FEMALE; GENE DELETION; GENETIC EPISTASIS; GENOTYPE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SEX DIFFERENCE;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; BASAL GANGLIA; DISEASE MODELS, ANIMAL; DOPAMINE; EPISTASIS, GENETIC; ETHANOL; GENOTYPE; HUMANS; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRODIALYSIS; NALOXONE; NUCLEUS ACCUMBENS; RECEPTORS, OPIOID, MU; REINFORCEMENT (PSYCHOLOGY); SEX CHARACTERISTICS;

EID: 34548147088     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.11.016     Document Type: Article

References (65)

1. Baamonde A.I., Hidalgo A., and Andres-Trelles F. Sex-related differences in the effects of morphine and stress on visceral pain. Neuropharmacology 28 (1989) 967-970
2. Bartok R.E., and Craft R.M. Sex differences in opioid antinociception. J Pharmacol Exp Ther 282 (1997) 769-778
3. Becker A., Grecksch G., Kraus J., Loh H.H., Schroeder H., and Hollt V. Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 365 (2002) 296-302
4. Belknap J.K., Crabbe J.C., and Young E.R. Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology (Berl) 112 (1993) 503-510
5. Borg P.J., and Taylor D.A. Involvement of mu- and delta-opioid receptors in the effects of systemic and locally perfused morphine on extracellular levels of dopamine, DOPAC and HVA in the nucleus accumbens of the halothane-anaesthetized rat. Naunyn Schmiedebergs Arch Pharmacol 355 (1997) 582-588
6. Bouza C., Angeles M., Munoz A., and Amate J.M. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 99 (2004) 811-828
7. Boyce-Rustay J.M., and Risinger F.O. Dopamine D3 receptor knockout mice and the motivational effects of ethanol. Pharmacol Biochem Behav 75 (2003) 373-379
8. Cahill L. Why sex matters for neuroscience. Nat Rev Neurosci 7 (2006) 477-484
9. Chefer V.I., Kieffer B.L., and Shippenberg T.S. Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice. Eur J Neurosci 18 (2003) 1915-1922
10. Cicero T.J., Nock B., and Meyer E.R. Gender-related differences in the antinociceptive properties of morphine. J Pharmacol Exp Ther 279 (1996) 767-773
11. Cicero T.J., Ennis T., Ogden J., and Meyer E.R. Gender differences in the reinforcing properties of morphine. Pharmacol Biochem Behav 65 (2000) 91-96
12. Cunningham C.L., Okorn D.M., and Howard C.E. Ethanol-induced conditioned place preference and activation in 15 inbred mouse strains. Alcohol Clin Exp Res 20 (1996) 59A
13. Dilts R.P., and Kalivas P.W. Autoradiographic localization of delta opioid receptors within the mesocorticolimbic dopamine system using radioiodinated [2-D- penicillamine, 5-D-penicillamine]enkephalin (125I-DPDPE). Synapse 6 (1990) 121-132
14. Doyon W.M., York J.L., Diaz L.M., Samson H.H., Czachowski C.L., and Gonzales R.A. Dopamine activity in the nucleus accumbens during consummatory phases of oral ethanol self-administration. Alcohol Clin Exp Res 27 (2003) 1573-1582
15. Dray A., and Nunan L. Evidence that naloxonazine produces prolonged antagonism of central delta opioid receptor activity in vivo. Brain Res 323 (1984) 123-127
16. Edenberg H.J., and Kranzler H.R. The contribution of genetics to addiction therapy approaches. Pharmacol Ther 108 (2005) 86-93
17. th edition (1996), Longman, Essex, England
18. Garbutt J.C., Kranzler H.R., O'Malley S.S., Gastfriend D.R., Pettinati H.M., Silverman B.L., et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA 293 (2005) 1617-1625
19. Gianoulakis C. Characterization of the effects of acute ethanol administration on the release of beta-endorphin peptides by the rat hypothalamus. Eur J Pharmacol 180 (1990) 21-29
20. Gianoulakis C. Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J Psychiatry Neurosci 26 (2001) 304-318
21. Gonzales R.A., and Weiss F. Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci 18 (1998) 10663-10671
22. Greenwell T.N., Zangen A., Martin-Schild S., Wise R.A., and Zadina J.E. Endomorphin-1 and -2 immunoreactive cells in the hypothalamus are labeled by fluoro-gold injections to the ventral tegmental area. J Comp Neurol 454 (2002) 320-328
23. Hall F.S., Sora I., and Uhl G.R. Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology (Berl) 154 (2001) 43-49
24. Honkanen A., Vilamo L., Wegelius K., Sarviharju M., Hyytia P., and Korpi E.R. Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats. Eur J Pharmacol 304 (1996) 7-13
25. Houghten R.A., Johnson N., and Pasternak G.W. [3H]-beta-endorphin binding in rat brain. J Neurosci 4 (1984) 2460-2465
26. Hyytia P. Involvement of mu-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol Biochem Behav 45 (1993) 697-701
27. Imperato A., and Di Chiara G. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther 239 (1986) 219-228
28. Johnson S.W., and North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 12 (1992) 483-488
29. Kest B., Wilson S.G., and Mogil J.S. Sex differences in supraspinal morphine analgesia are dependent on genotype. J Pharmacol Exp Ther 289 (1999) 1370-1375
30. Khachaturian H., Lewis M.E., and Watson S.J. Enkephalin systems in diencephalon and brainstem of the rat. J Comp Neurol 220 (1983) 310-320
31. Kiefer F., Jahn H., and Wiedemann K. A neuroendocrinological hypothesis on gender effects of naltrexone in relapse prevention treatment. Pharmacopsychiatry 38 (2005) 184-186
32. Kornet M., Goosen C., and Van Ree J.M. Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys. Psychopharmacology (Berl) 104 (1991) 367-376
33. Kranzler H.R., and Van Kirk J. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res 25 (2001) 1335-1341
34. Krishnan-Sarin S., Jing S.L., Kurtz D.L., Zweifel M., Portoghese P.S., Li T.K., and Froehlich J.C. The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference. Psychopharmacology (Berl) 120 (1995) 177-185
35. Krishnan-Sarin S., Wand G.S., Li X.W., Portoghese P.S., and Froehlich J.C. Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking. Pharmacol Biochem Behav 59 (1998) 627-635
36. Le A.D., Poulos C.X., Quan B., and Chow S. The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm. Brain Res 630 (1993) 330-332
37. Ling G.S., Simantov R., Clark J.A., and Pasternak G.W. Naloxonazine actions in vivo. Eur J Pharmacol 129 (1986) 33-38
38. Loh H.H., Liu H.C., Cavalli A., Yang W., Chen Y.F., and Wei L.N. mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 54 (1998) 321-326
39. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J Neurosci 7 (1987) 2445-2464
40. Marinelli P.W., Lam M., Bai L., Quirion R., and Gianoulakis C. A microdialysis profile of dynorphin A (1-8) release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res 30 (2006) 982-990
41. Marinelli P.W., Quirion R., and Gianoulakis C. A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration. Psychopharmacology (Berl) 169 (2003) 60-67
42. Mason B.J., Salvato F.R., Williams L.D., Ritvo E.C., and Cutler R.B. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 56 (1999) 719-724
43. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 (1996) 819-823
44. Melendez R.I., Rodd-Henricks Z.A., Engleman E.A., Li T.K., McBride W.J., and Murphy J.M. Microdialysis of dopamine in the nucleus accumbens of alcohol-preferring (P) rats during anticipation and operant self-administration of ethanol. Alcohol Clin Exp Res 26 (2002) 318-325
45. Nocjar C., Middaugh L.D., and Tavernetti M. Ethanol consumption and place-preference conditioning in the alcohol-preferring C57BL/6 mouse: relationship with motor activity patterns. Alcohol Clin Exp Res 23 (1999) 683-692
46. Olive M.F., Koenig H.N., Nannini M.A., and Hodge C.W. Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J Neurosci 21 (2001) RC184(1-5)
47. Olive M.F., Mehmert K.K., Messing R.O., and Hodge C.W. Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCepsilon-deficient mice. Eur J Neurosci 12 (2000) 4131-4140
48. Oslin D.W., Berrettini W., Kranzler H.R., Pettinati H., Gelernter J., Volpicelli J.R., and O'Brien C.P. A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28 (2003) 1546-1552
49. Paulson P.E., and Robinson T.E. Relationship between circadian changes in spontaneous motor activity and dorsal versus ventral striatal dopamine neurotransmission assessed with on-line microdialysis. Behav Neurosci 108 (1994) 624-635
50. Paxinos G., and Franklin K.B.J. The mouse brain in stereotaxic coordinates (2001), Academic Press, San Diego, CA
51. Ray L.A., and Hutchison K.E. A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 28 (2004) 1789-1795
52. Roberts A.J., McDonald J.S., Heyser C.J., Kieffer B.L., Matthes H.W., Koob G.F., and Gold L.H. mu-Opioid receptor knockout mice do not self-administer alcohol. J Pharmacol Exp Ther 293 (2000) 1002-1008
53. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18 (1993) 247-291
54. Schuller A.G., King M.A., Zhang J., Bolan E., Pan Y.X., Morgan D.J., et al. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci 2 (1999) 151-156
55. Schultz W., Dayan P., and Montague P.R. A neural substrate of prediction and reward. Science 275 (1997) 1593-1599
56. Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., et al. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A 94 (1997) 1544-1549
57. Spanagel R., Herz A., and Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A 89 (1992) 2046-2050
58. Svingos A.L., Clarke C.L., and Pickel V.M. Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell: implications for opiate and psychostimulant cross-sensitization. Synapse 34 (1999) 1-10
59. Tanda G., and Di Chiara G. A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and nonpsychostimulant drugs of abuse. Eur J Neurosci 10 (1998) 1179-1187
60. Tang A., George M.A., Randall J.A., and Gonzales R.A. Ethanol increases extracellular dopamine concentration in the ventral striatum in C57BL/6 mice. Alcohol Clin Exp Res 27 (2003) 1083-1089
61. Tian M., Broxmeyer H.E., Fan Y., Lai Z., Zhang S., Aronica S., et al. Altered hematopoiesis, behavior, and sexual function in mu opioid receptor-deficient mice. J Exp Med 185 (1997) 1517-1522
62. Volpicelli J.R., Alterman A.I., Hayashida M., and O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49 (1992) 876-880
63. Walther T., Voigt J.P., Fink H., and Bader M. Sex specific behavioural alterations in Mas-deficient mice. Behav Brain Res 107 (2000) 105-109
64. Weiss F., Lorang M.T., Bloom F.E., and Koob G.F. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther 267 (1993) 250-258
65. Yoshida Y., Koide S., Hirose N., Takada K., Tomiyama K., Koshikawa N., and Cools A.R. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors. Neuroscience 92 (1999) 1357-1365